Subtopic Deep Dive

Radiomics in Cancer Precision Medicine
Research Guide

What is Radiomics in Cancer Precision Medicine?

Radiomics in cancer precision medicine extracts quantitative imaging features to correlate with genomic data for patient stratification and personalized therapy selection.

This subtopic integrates radiomics features from medical images with molecular profiles to predict treatment outcomes in cancer patients. Key studies include Bakas et al. (2017) providing glioma MRI radiomic features (2740 citations) and Lambin et al. (2012) on multifactorial decision support in radiation oncology (389 citations). Over 10 papers from the list advance radiogenomics associations.

15
Curated Papers
3
Key Challenges

Why It Matters

Radiomics enables non-invasive imaging biomarkers for therapy response prediction, as in O’Connor et al. (2016) roadmap for cancer studies (1034 citations). It supports patient stratification in gliomas via expert-labeled datasets (Bakas et al., 2017). Applications include personalized radiation dosing (Lambin et al., 2012) and PET-based heterogeneity analysis (Cook et al., 2014), improving survival predictions without biopsies.

Key Research Challenges

Radiomic Feature Reproducibility

Variations in image acquisition and preprocessing lead to inconsistent features across scanners (van Timmeren et al., 2020; 1169 citations). Standardization protocols remain underdeveloped. Rizzo et al. (2018) highlight segmentation and extraction challenges (1004 citations).

Radiogenomics Correlation Validation

Linking imaging phenotypes to molecular pathways requires large datasets with paired imaging-genomic data (Bakas et al., 2017). Few studies validate associations prospectively. Mayerhoefer et al. (2020) note heterogeneity capture limitations (1582 citations).

Clinical Translation Barriers

Models from radiomics lack prospective trials for precision medicine integration (Lambin et al., 2012). Privacy in federated learning for multi-center data is critical (Rieke et al., 2020; 2068 citations). O’Connor et al. (2016) outline biomarker validation roadmaps.

Essential Papers

1.

Advancing The Cancer Genome Atlas glioma MRI collections with expert segmentation labels and radiomic features

Spyridon Bakas, Hamed Akbari, Aristeidis Sotiras et al. · 2017 · Scientific Data · 2.7K citations

2.

The future of digital health with federated learning

Nicola Rieke, Jonny Hancox, Wenqi Li et al. · 2020 · npj Digital Medicine · 2.1K citations

3.

Introduction to Radiomics

Marius E. Mayerhoefer, Andrzej Materka, Georg Langs et al. · 2020 · Journal of Nuclear Medicine · 1.6K citations

Radiomics is a rapidly evolving field of research concerned with the extraction of quantitative metrics-the so-called radiomic features-within medical images. Radiomic features capture tissue and l...

4.

Radiomics in medical imaging—“how-to” guide and critical reflection

Janita E. van Timmeren, D. Cester, Stephanie Tanadini‐Lang et al. · 2020 · Insights into Imaging · 1.2K citations

5.

Secure, privacy-preserving and federated machine learning in medical imaging

Georgios Kaissis, Marcus R. Makowski, Daniel Rückert et al. · 2020 · Nature Machine Intelligence · 1.1K citations

6.

A deep learning algorithm using CT images to screen for Corona virus disease (COVID-19)

Shuai Wang, Bo-Kyeong Kang, Jinlu Ma et al. · 2021 · European Radiology · 1.1K citations

7.

Imaging biomarker roadmap for cancer studies

James P.B. O’Connor, Eric O. Aboagye, Judith E. Adams et al. · 2016 · Nature Reviews Clinical Oncology · 1.0K citations

Reading Guide

Foundational Papers

Start with Lambin et al. (2012) for radiomics decision support in oncology and Cook et al. (2014) for PET applications, as they establish prediction frameworks.

Recent Advances

Study Bakas et al. (2017) for glioma radiomic datasets and Mayerhoefer et al. (2020) for radiomics introduction, capturing high-citation advances.

Core Methods

Core techniques: quantitative feature extraction (shape, texture; Rizzo et al., 2018), TCGA glioma segmentation (Bakas et al., 2017), biomarker roadmaps (O’Connor et al., 2016).

How PapersFlow Helps You Research Radiomics in Cancer Precision Medicine

Discover & Search

Research Agent uses searchPapers and exaSearch to find radiogenomics papers like Bakas et al. (2017), then citationGraph reveals 2740 citing works on glioma precision medicine, and findSimilarPapers uncovers related TCGA datasets.

Analyze & Verify

Analysis Agent applies readPaperContent to extract radiomic features from Bakas et al. (2017), verifies correlations via verifyResponse (CoVe) against Mayerhoefer et al. (2020), and runs PythonAnalysis for feature reproducibility stats with NumPy/pandas, graded by GRADE for evidence strength.

Synthesize & Write

Synthesis Agent detects gaps in radiogenomics validation from Lambin et al. (2012) and O’Connor et al. (2016), flags contradictions in feature stability; Writing Agent uses latexEditText, latexSyncCitations for reports, and latexCompile for manuscripts with exportMermaid diagrams of imaging-genomic pathways.

Use Cases

"Reproduce radiomic feature stats from Bakas glioma dataset"

Research Agent → searchPapers('Bakas 2017 glioma radiomics') → Analysis Agent → readPaperContent → runPythonAnalysis (NumPy/pandas for heterogeneity metrics) → matplotlib plots of feature distributions.

"Write LaTeX review on radiomics for cancer stratification"

Synthesis Agent → gap detection (Lambin 2012, O’Connor 2016) → Writing Agent → latexEditText(draft) → latexSyncCitations(10 papers) → latexCompile → PDF with radiogenomics flowchart via exportMermaid.

"Find code for TCGA glioma radiomics analysis"

Research Agent → searchPapers('Bakas 2017') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → verified Python scripts for feature extraction.

Automated Workflows

Deep Research workflow scans 50+ papers on radiomics precision medicine via searchPapers → citationGraph, producing structured reports with GRADE-scored evidence from Bakas et al. (2017). DeepScan applies 7-step analysis with CoVe checkpoints to validate radiogenomic models from Mayerhoefer et al. (2020). Theorizer generates hypotheses linking PET radiomics (Cook et al., 2014) to genomic pathways.

Frequently Asked Questions

What defines radiomics in cancer precision medicine?

It extracts quantitative features from tumor images to correlate with genomics for therapy personalization (Mayerhoefer et al., 2020).

What are core methods in this subtopic?

Methods include feature extraction for heterogeneity/shape (Rizzo et al., 2018) and decision support models (Lambin et al., 2012).

What are key papers?

Foundational: Lambin et al. (2012, 389 citations); recent: Bakas et al. (2017, 2740 citations), Mayerhoefer et al. (2020, 1582 citations).

What are open problems?

Challenges include reproducibility (van Timmeren et al., 2020), validation of imaging-genomic links (Bakas et al., 2017), and federated data sharing (Rieke et al., 2020).

Research Radiomics and Machine Learning in Medical Imaging with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Radiomics in Cancer Precision Medicine with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers